Studies have shown that GSDMC may act as an oncogene to promote the occurrence of colorectal and lung adenocarcinoma [66], while GSDME acts as a tumor suppressor in breast and liver cancer [67]. The gene discussed is GSDMC; the disease is neoplasm.